Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...

It's no secret that doctors are helping many people lose weight by prescribing GLP-1 medications like Ozempic, Wegovy, ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...

a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).

Two novel drugs for treating Alzheimer's have been rejected for use on the NHS, despite gaining approval from the UK ...

The new Netflix thriller Don't Move depicts a woman injected with a paralytic agent, but gets the science behind how these ...

Dementia is a progressive condition that impacts a person's brain function, resulting in a decline of cognitive skills such ...

A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...

There is a potential breakthrough for patients who could be in danger of losing their vision. A first-of-its-kind treatment is now being used in Massachusetts. Kevin Ratcliffe is a glaucoma patient at ...

Scientists at Case Western Reserve University’s School of Medicine have discovered that semaglutide, a well-known drug used ...

a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D). Alzheimer's disease is a brain disorder that slowly destroys memory and ...